查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511808

牙周病治療藥物市場規模、佔有率、趨勢分析報告：依疾病、藥物類型、通路、地區、細分市場預測，2024-2030年

Periodontal Therapeutics Market Size, Share & Trends Analysis Report By Disease, By Drug Type, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

牙周病治療藥物市場成長及趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球牙周藥物市場規模預計將達到14.1億美元，2024年至2030年複合年成長率為7.2%。

這個市場主要是由於老年人口增加而導致牙周病盛行率不斷上升所推動的。根據NCBI 2023年9月發表的報導，預計受這種疾病影響的老年人比例將從2020年的42.44%上升到2050年的54.57%。預計輕度牙周病仍是最常見的，佔80.39%。此外，2020 年至 2050 年間，未經治療的蛀牙數量預計將增加 75.2%。

人們對口腔健康的認知不斷提高正在推動市場成長。利用形成性需求評估的資料進行了許多宣傳活動，以關注不同人群牙齒健康狀況不佳這一更廣泛的問題。這些舉措旨在提高人們對牙周健康的認知和知識，促進自我護理預防性牙科行為，並鼓勵利用牙科保健服務。有些宣傳活動是針對特定人口群體的，例如成人、兒童、嬰幼兒父母以及被認為牙齒問題風險較高的社會經濟弱勢群體。挪威的 Perio Year宣傳活動旨在提高 15 歲及以上人群的意識提升。作為宣傳活動的一部分，牙醫接受了一年的培訓，以在患者就診期間強化宣傳活動的訊息。該宣傳活動利用各種媒體管道，並向雜貨店、藥房和牙科診所分發資訊手冊。

與牙周病相關的抗生素抗藥性細菌的出現需要一些重要的行動和考慮。例如，2022 年 10 月，一項重點評估與牙周病相關的微生物的抗菌藥物抗藥性的研究強調了繼續研究以了解這些細菌的抗藥性程度的重要性。這項研究強調需要開發標靶治療和策略來有效解決抗菌素抗藥性。這項研究強調了醫療保健專業人員不加區別地開抗生素處方對抗菌素抗藥性的有害影響。這凸顯了遵守正確治療方案的重要性以及醫療保健專業人員了解他們所處理的細菌的抗藥性模式的必要性。

此外，巨量資料挖掘、系統生物學和深度學習方法的整合對藥物開發的技術進步產生了重大影響。這些進展旨在促進新藥的發現和開發，用於治療以牙齦和牙周組織發炎和感染為特徵的疾病。一個重要的方法是利用巨量資料挖掘來分析全基因組微陣列資料集，例如 GSE10334資料集，其中包括來自中度至重度牙周炎患者的資料。這種方法能夠識別疾病過程中涉及的候選基因、蛋白質-蛋白質相互作用 (PPIN) 網路和調控網路 (GRN)。透過應用系統識別和系統順序檢測方法，研究人員可以為患病和健康對照組確定真正的全基因表現網路（GWGEN）。這一步驟對於闡明疾病的分子機制和確定藥物開發的潛在標靶至關重要。

牙周病治療藥物市場報告亮點

  • 2023年，慢性牙周病細分市場佔最大市場。這是由於患者明顯不適導致治療率高、治療依從率高、盛行率整體上升。
  • 2023年，多西環素藥物主導市場。強力黴素已被證明可以抑制基質金屬蛋白酶 8 (MMP-8)，這種酶通常與牙周炎有關，即使濃度較低。
  • 2023年醫院藥局分銷管道佔最大市場佔有率。該細分市場的成長是由醫院的高處方率、患者對從醫院藥房購買處方藥的高偏好以及因牙周病到醫院就診的患者的增加所推動的。
  • 由於先進的醫療基礎設施、疾病盛行率上升以及有利的法規環境等因素，北美在市場上佔據主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章牙周病治療市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 牙周病治療藥物市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析

第4章牙周病治療藥物市場：疾病估計與趨勢分析

  • 全球牙周病治療藥物市場：特定疾病儀表板
  • 全球牙周病治療藥物市場：依疾病區分的波動分析
  • 全球牙周病治療藥物市場：依疾病和收益
  • 牙齦炎
  • 慢性牙周病
  • 進行性牙周病
  • 其他

第5章牙周病治療藥物市場：藥物種類預估及趨勢分析

  • 全球牙周藥物市場：按藥物類型分類的儀表板
  • 全球牙周病治療藥物市場：依藥物類型波動分析
  • 全球牙周病藥物市場：依藥物類型和收益
  • 強力黴素
  • 米諾四環素
  • 洛赫西定
  • 甲硝唑
  • 其他

第6章牙周病治療藥物市場：通路估算及趨勢分析

  • 全球牙周病藥物市場：按分銷管道分類的儀表板
  • 全球牙周病治療藥物市場：依通路波動分析
  • 全球牙周病治療藥物市場：依通路及收益
  • 醫院藥房
  • 零售藥房
  • 線上管道

第7章 牙周病治療藥物市場：按疾病、藥物類型和分銷管道分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場占有率分析
    • Pfizer Inc.
    • Lupin Ltd
    • Teva Pharmaceuticals USA, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Tokyo Chemical Industry Co., Ltd.
    • Bausch Health Companies Inc.
    • USAntibiotics
    • Melinta Therapeutics LLC
    • Cipla, Inc.
    • Chartwell Pharmaceuticals LLC.
Product Code: GVR-4-68040-295-7

Periodontal Therapeutics Market Growth & Trends:

The global periodontal therapeutics market size is anticipated to reach USD 1.41 billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing prevalence of periodontal diseases aided by the growing geriatric population. According to an article published by NCBI, in September 2023, the percentage of older adults affected by the disease is anticipated to rise from 42.44% in 2020 to 54.57% by 2050. Mild periodontal diseases are predicted to continue being the most common type, accounting for 80.39% of cases. Additionally, the number of untreated cavities in teeth is expected to increase by 75.2% between 2020 and 2050.

Increasing awareness about oral health fuels the growth of the market. Numerous campaigns have been created using data from formative needs assessments, focusing on the widespread issue of poor dental health in various populations. These initiatives aimed to increase awareness and knowledge about periodontal health, promote self-care dental preventive behaviors, and encourage the utilization of dental health services. Certain campaigns were tailored to specific demographics, including adults, children, parents of infants, and disadvantaged socio-economic groups considered to be at higher risk for dental problems. The Perio-Year Campaign in Norway targeted individuals aged 15 and above to increase awareness. As part of the initiative, dentists received one year of training to reinforce campaign messages during patient consultations. The campaign utilized diverse media channels and distributed informational booklets to grocery stores, pharmacies, and dental offices.

The emergence of antibiotic-resistant strains of bacteria associated with periodontal diseases necessitates several key actions and considerations. For instance, in October 2022, a research study focused on assessing antimicrobial resistance in microorganisms associated with periodontal diseases underscores the importance of ongoing research in understanding the scope of resistance among these bacteria. This investigation highlights the necessity for developing targeted treatments and strategies to address antibiotic resistance effectively.The study emphasizes the detrimental impact of healthcare professionals on antimicrobial resistance due to indiscriminate prescribing of antimicrobials. This emphasizes the significance of adhering to appropriate prescribing practices and the necessity for healthcare providers to possess awareness regarding the resistance patterns of the bacteria they are addressing.

Furthermore, technological advancements in drug development have been significantly influenced by the integration of big data mining, systems biology, and deep learning methods. These advancements aim to enhance the discovery and development of novel drugs for the treatment of the diseases, which are characterized by inflammation and infection in the gums and periodontal tissues. One key methodology involves leveraging big data mining to analyze genome-wide microarray datasets, such as the GSE10334 dataset, which contains data from individuals with moderate to severe periodontitis. This approach enables the identification of candidate genes, protein-protein interaction (PPIN) networks, and regulatory networks (GRNs) involved in the disease process. Applying system identification and system order detection methods, researchers can pinpoint genuine gene-wide gene expression networks (GWGENs) for both diseased and healthy control groups. This step is crucial for elucidating the molecular mechanisms underlying the disease and identifying potential targets for drug development.

Periodontal Therapeutics Market Report Highlights:

  • The chronic periodontal disease segment held the largest share of the market in 2023. It can be attributed to the high treatment rate of the disease due to significant discomfort to the patients, high treatment adherence rate, and overall, a growing prevalence of the disease.
  • The doxycycline drug type dominated the market in 2023. Doxycycline, even at lower concentrations, has been found to inhibit matrix metalloproteinase-8 (MMP-8), an enzyme abundant in periodontitis.
  • Hospital pharmacies distribution channel held the largest share of the market in 2023. The high prescription rates at hospitals, high patient preference of purchase prescribed medications from hospital pharmacies, and increasing number of patients visiting hospitals for periodontal diseases are driving the growth of this segment.
  • North America dominated the market owing to factors such as advanced healthcare infrastructure, rising prevalence of the disease, and favorable regulatory environment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Drug Type
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease and Drug Type outlook
    • 2.2.2. Distribution Channel outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Periodontal Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of periodontal diseases
      • 3.2.1.2. Increasing awareness about oral health
      • 3.2.1.3. Rising geriatric population
      • 3.2.1.4. Technological advancements in dentistry
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited awareness and education for oral health
      • 3.2.2.2. Stringent regulatory policies
  • 3.3. Periodontal Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Periodontal Therapeutics Market: Disease Estimates & Trend Analysis

  • 4.1. Global Periodontal Therapeutics Market: Disease Dashboard
  • 4.2. Global Periodontal Therapeutics Market: Disease Movement Analysis
  • 4.3. Global Periodontal Therapeutics Market by Disease, Revenue
  • 4.4. Gingivitis
    • 4.4.1. Gingivitis market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Chronic Periodontal Disease
    • 4.5.1. Chronic Periodontal Disease market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Aggressive Periodontal Disease
    • 4.6.1. Aggressive Periodontal Disease market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Periodontal Therapeutics Market: Drug Type Estimates & Trend Analysis

  • 5.1. Global Periodontal Therapeutics Market: Drug Type Dashboard
  • 5.2. Global Periodontal Therapeutics Market: Drug Type Movement Analysis
  • 5.3. Global Periodontal Therapeutics Market by Drug Type, Revenue
  • 5.4. Doxycycline
    • 5.4.1. Doxycycline market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Minocycline
    • 5.5.1. Minocycline market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Chlorhexidine
    • 5.6.1. Chlorhexidine market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Metronidazole
    • 5.7.1. Metronidazole market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Other drug types
    • 5.8.1. Other drug types market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Periodontal Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Periodontal Therapeutics Market: Distribution Channel Dashboard
  • 6.2. Global Periodontal Therapeutics Market: Distribution Channel Movement Analysis
  • 6.3. Global Periodontal Therapeutics Market by Distribution Channel, Revenue
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Online Channel
    • 6.6.1. Online Channel market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Periodontal Therapeutics Market: Regional Estimates & Trend Analysis by Disease, Drug Type, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Pfizer Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Lupin Ltd
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Teva Pharmaceuticals USA, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sun Pharmaceutical Industries Ltd.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Tokyo Chemical Industry Co., Ltd.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Bausch Health Companies Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. USAntibiotics
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Melinta Therapeutics LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Cipla, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Chartwell Pharmaceuticals LLC.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 4 North America periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 5 North America periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 7 U.S. periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 8 U.S. periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Canada periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 10 Canada periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 11 Canada periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Europe periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 14 Europe periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 15 Europe periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 16 Germany periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 17 Germany periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 18 Germany periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 UK periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 20 UK periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 21 UK periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 23 France periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 24 France periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Italy periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 26 Italy periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 27 Italy periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Spain periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 29 Spain periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 30 Spain periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Denmark periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 32 Denmark periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 33 Denmark periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Sweden periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 35 Sweden periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 36 Sweden periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Norway periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 38 Norway periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 39 Norway periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 China periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 45 China periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 46 China periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Japan periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 48 Japan periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 49 Japan periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 India periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 51 India periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 52 India periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 South Korea periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 54 South Korea periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 55 South Korea periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Australia periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 57 Australia periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 58 Australia periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 Thailand periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 60 Thailand periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 61 Thailand periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Latin America periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 64 Latin America periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 65 Latin America periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 66 Brazil periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 67 Brazil periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 68 Brazil periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 69 Mexico periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 70 Mexico periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 71 Mexico periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 73 Argentina periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 74 Argentina periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75 MEA periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 77 MEA periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 78 MEA periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 80 South Africa periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 81 South Africa periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 UAE periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 86 UAE periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 87 UAE periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 89 Kuwait periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 90 Kuwait periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 periodontal therapeutics market: market outlook
  • Fig. 14 Periodontal Therapeutics competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 periodontal therapeutics market driver impact
  • Fig. 18 periodontal therapeutics market restraint impact
  • Fig. 19 periodontal therapeutics market: Disease movement analysis
  • Fig. 20 periodontal therapeutics market: Disease outlook and key takeaways
  • Fig. 21 Gingivitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Chronic Periodontal Disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Aggressive Periodontal Disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 periodontal therapeutics market: Drug Type movement analysis
  • Fig. 26 periodontal therapeutics market: Drug Type outlook and key takeaways
  • Fig. 27 Doxycycline market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Minocycline market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chlorhexidine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Metronidazole market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other drug types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 periodontal therapeutics market: Distribution Channel movement analysis
  • Fig. 33 periodontal therapeutics market: Distribution Channel outlook and key takeaways
  • Fig. 34 Hospital Pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Retail Pharmacies estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Online Channel market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Global periodontal therapeutics market: Regional movement analysis
  • Fig. 38 Global periodontal therapeutics market: Regional outlook and key takeaways
  • Fig. 39 Global periodontal therapeutics market share and leading players
  • Fig. 40 North America, by country
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK key country dynamics
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany key country dynamics
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 France key country dynamics
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Italy key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain key country dynamics
  • Fig. 56 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark key country dynamics
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Sweden key country dynamics
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Norway key country dynamics
  • Fig. 62 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 China key country dynamics
  • Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Japan key country dynamics
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 India key country dynamics
  • Fig. 69 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand key country dynamics
  • Fig. 71 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 South Korea key country dynamics
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Australia key country dynamics
  • Fig. 75 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Brazil key country dynamics
  • Fig. 78 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Mexico key country dynamics
  • Fig. 80 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Argentina key country dynamics
  • Fig. 82 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa key country dynamics
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Saudi Arabia key country dynamics
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 UAE key country dynamics
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait key country dynamics
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Market share of key market players - periodontal therapeutics market